Picture of Mercia Asset Management logo

MERC Mercia Asset Management News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsAdventurousSmall CapNeutral

REG - Mercia Asset Mgt PLC - Interim Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221206:nRSF6761Ia&default-theme=true

RNS Number : 6761I  Mercia Asset Management PLC  06 December 2022

 RNS   6 December 2022

 

Mercia Asset Management PLC

("Mercia" or the "Group" or the "Company")

 

Interim results for the six months ended 30 September 2022

 

Continuing profitable progress and a strong balance sheet, underpins a 10%
increase in the interim dividend

 

Mercia Asset Management PLC (AIM: MERC), the proactive regionally focused,
profitable specialist asset manager with c.£979million of assets under
management ("AuM"), is pleased to announce its interim results for the six
months ended 30 September 2022.

 

Highlights

·    Adjusted operating profit up c.50% to £3.6million (H1 2022:
£2.4million)

·    £5.6million fair value increase in direct investments (H1 2022:
£8.7million)

·    Profit before taxation of £7.4million (H1 2022: £11.0million)

·    Interim dividend up c.10% to 0.33 pence per share (H1 2022: 0.30
pence per share)

·    Robust balance sheet with cash and short-term liquidity investments
of £56.1million as at 30 September 2022 (H1 2022: £52.1million; FY 2022:
£61.3million)

·    Group AuM of £979.4million (H1 2022: £948.4million; FY 2022:
£959.2million), with a c.10% increase in the fair value of the direct
investment portfolio from 31 March 2022

·    Net assets per share up c.3% to 46.8 pence (H1 2022: 42.4 pence; FY
2022: 45.6 pence)

 

Financial results

                                                                Unaudited      Unaudited         Audited

                                                                30 September   30 September      31 March

                                                                2022           2021              2022
 Statutory results
                    Revenue                                     £12.2m         £12.7m            £23.2m
                    Realised gain on sale of direct investment  -              -                 £9.9m
                    Fair value movements in direct investments  £5.6m          £8.7m             £11.4m
                    Operating profit                            £5.9m          £10.7m            £22.9m
                    Profit before taxation                      £7.4m          £11.0m            £27.4m
                    Basic earnings per share                    1.6p           2.5p              5.9p

                    Interim dividend per share (1)              0.33p          0.30p             0.30p
                    Final dividend per share                    -              -                 0.50p

                    Cash and short-term liquidity investments   £56.1m         £52.1m            £61.3m
                    Net assets                                  £206.0m        £186.4m           £200.6m

 Alternative performance measures
                    Adjusted operating profit (2)               £3.6m          £2.4m             £8.4m
                    Net assets per share                        46.8p          42.4p             45.6p
                    AuM                                         £979.4m        £948.4m           £959.2m

 

1    The interim dividend will be payable to shareholders on the register
on 16 December 2022 and will be paid on 4 January 2023.

2    Adjusted operating profit is defined as operating profit before
exceptional net performance fees, realised gains on disposal of investments,
fair value movements in investments, share-based payments charge,
depreciation, amortisation of intangible assets, movement in fair value of
deferred consideration and exceptional items. It includes net finance income.
A reconciliation of operating profit to adjusted operating profit is included
in the Chief Financial Officer's review.

 

Managed fund developments

·    Third-party funds under management ("FuM") of c.£773million (H1
2022: c.£762million; FY 2022: c.£758million)

o  Venture FuM c.£611million (H1 2022: c.£601million; FY 2022:
c.£592million)

§ £40.0million successfully raised by the three Northern Venture Capital
Trusts ("VCTs")

§ First Knowledge-intensive Impact Enterprise Investment Scheme ("EIS") and
Q3 2022 EIS Funds raised a combined c.£13million during the period

§ Interim and final dividends totalling £10.1million paid by the three
Northern VCTs

o  Private equity FuM c.£46million (H1 2022: c.£53million; FY 2022:
c.£48million)

o  Debt FuM c.£116million (H1 2022: c.£108million; FY 2022 c.£118million)

§ Accreditation awarded to the Group to deliver debt funding under the third
phase of the Recovery Loan Scheme ("RLS")

 

Direct investment portfolio developments

·    Direct investment portfolio fair value of £131.5million (H1 2022:
£110.3million; FY 2022: £119.6million), up c.10% from 31 March 2022 despite
the UK macroeconomic backdrop and global geopolitical instability

·    £6.4million net invested into six portfolio companies (H1 2022:
£5.4million net invested into five portfolio companies), including a new
direct investment into Uniphy Limited ("Uniphy")

·    £5.6million fair value increase in the portfolio during the
six-month period (H1 2022: £8.7million)

·    Demerger of Intechnica Limited's ("Intechnica") cybersecurity
bot-management business Netacea Limited ("Netacea") completed during the
period, allowing both companies to benefit from a refined focus on their
respective target markets

 

Post period end developments

·    Investments totalling £5.3million completed into two new direct
portfolio companies, Axis Spine Technologies Limited ("Axis Spine") and Nova
Pangaea Technologies Limited ("Nova Pangaea")

o  Axis Spine is a Med Tech business delivering spinal implants designed to
address the increasingly recognised and unmet clinical need of cage subsidence

o  Nova Pangaea is a Clean Tech business focused on creating biofuels and
biochar to address some of the most pressing climate concerns of today

·    A £3.0million investment has been made into Netacea to fund its
commercial expansion

·    £11.5million additional allocation from British Business Bank
("BBB") under the Midlands Engine Investment Proof-of-Concept Fund ("MEIF")

·    Commercial progress continues to be made overall by the direct
investment portfolio

·    Acquisition of Frontier Development Capital Limited ("FDC") for an
initial cash consideration of £5.5million, adding c.£415million of
profitable FuM to the Group

 

Mark Payton, Chief Executive Officer of Mercia, commented:

"In these challenging times, both nationally and globally, the resilience of
Mercia's hybrid investment model is evident as we continue to drive growth in
assets under management, net asset value per share and our progressive
dividend. Our debt-free balance sheet and significant liquidity means Mercia
is well placed to capitalise at a time in the cycle when there are compelling
opportunities to be had. These results also showcase our track record of
delivery, with Mercia having returned c.£280million back to our fund
investors since April 2020. With our strong cash position, exceptional team
and proven ability to generate attractive returns across asset classes, we
continue to look forward with confidence as we progress towards our Mercia
'20:20' targets."

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 which is part of UK law by virtue of
the European Union (Withdrawal) Act 2018. Upon publication of this
announcement, this inside information is now considered to be in the public
domain.

 

-Ends-

 

For further information, please contact:

 

 Mercia Asset Management PLC                                 +44 (0)330 223 1430

 Mark Payton, Chief Executive Officer

 Martin Glanfield, Chief Financial Officer

 www.mercia.co.uk (http://www.mercia.co.uk/)

 Canaccord Genuity Limited (NOMAD and Joint Broker)          +44 (0)20 7523 8000
 Simon Bridges, Emma Gabriel

 Singer Capital Markets (Joint Broker)                                +44 (0)20 7496 3000
 Harry Gooden, James Moat

 FTI Consulting                                                        +44 (0)20 3727 1051
 Tom Blackwell, Immy Ransom
 mercia@fticonsulting.com (mailto:mercia@fticonsulting.com)

 

 

Analyst briefing

An analyst webcast will be given by Dr Mark Payton, Chief Executive Officer,
Martin Glanfield, Chief Financial Officer, and Julian Viggars, Chief
Investment Officer, at 9.30am today, 6 December 2022. Analysts wishing to
register are asked to contact mercia@fticonsulting.com
(mailto:mercia@fticonsulting.com) . An audio webcast of this briefing will
subsequently be available later in the day via Mercia's website.

Investor presentation

In addition, as part of its continuing commitment to appropriate and open
communication with all shareholders and its wider stakeholder community,
Mercia will provide a live management presentation and Q&A via the
Investor Meet Company ("IMC") platform at 3.00pm today. Registration details
can be accessed via:

https://www.investormeetcompany.com/mercia-asset-management-plc/register-investor
(https://www.investormeetcompany.com/mercia-asset-management-plc/register-investor)

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional
SMEs to achieve their growth aspirations. Mercia provides capital across its
four asset classes of venture, private equity, debt and proprietary capital:
the Group's 'Complete Connected Capital'. The Group initially nurtures
businesses via its third-party funds under management, then over time Mercia
can provide further funding to the most promising companies, by deploying
direct investment follow-on capital from its own balance sheet.

The Group has a strong UK footprint through its regional offices, university
partnerships and extensive personal networks, providing it with access to
high-quality deal flow.

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

 

 

Chief Executive Officer's Review

Introduction

In these challenging times, it is pleasing to report continued, steady
momentum at Mercia. We are in the strong position of being able to build from
a solid base, providing support for founders and managers of many of the UK's
leading SMEs, to enable them to focus on long-term growth. Key metrics that
demonstrate the resilience of Mercia's hybrid investment model during these
times include:

·    Like-for-like revenue increase of 8% to £12.2million

·    Adjusted operating profit increase of c.50% to £3.6million

·    Interim dividend up c.10% to 0.33 pence per share

·    Nets assets per share increased by c.3% to 46.8 pence

·    AuM of c.£979million, with a c.10% increase in the fair value of the
direct investment portfolio from 31 March 2022.

Our vision remains to become the first choice for investees, investors and
employees. At this midpoint in our current three-year Mercia '20:20' strategic
plan, we remain confident that we will achieve our goals of £60.0million in
cumulative pre-tax profits and c.£600million cumulative growth in AuM by 31
March 2024. With the acquisition of FDC alongside organic growth in FuM, AuM
is now c.£1.4billion. The positive progress being made against these twin
goals continues to underpin our progressive dividend policy.

Distribution, in terms of both organic FuM growth and deal origination, is
critical to Mercia's continued success and scale and is underpinned by our
nine offices across the regions. Furthermore, all the capital that we manage
is in closed-end or evergreen structures, providing a stable source of
long-term third-party capital which is not subject to redemptions. This allows
the team to progressively spot and build value without the vulnerability of
capital withdrawal from our managed funds. The pools of capital we manage are
split into (i) 'retail' ie individual investors (via Mercia's EIS and Northern
VCTs), (ii) government agencies (both national and regional) and (iii)
institutional capital (typically regional pension funds).

Strength in numbers: A reputation for delivery

Mercia's hybrid model of combining interlinked, risk-adjusted third-party FuM
with scale-up capital via Mercia's balance sheet, ensures the supply of the
right capital to the right business at the right time. This hybrid investment
model originated in 2010 ahead of Mercia's IPO in 2014, and now delivers a
critical mass and maturity that is helping deliver returns to our fund
investors and shareholders as well as, crucially, to the founders and managers
of our investees whom we have the great privilege of supporting. In addition,
Mercia's management of our EIS funds and Northern VCTs consistently scores
highly with external reviewers who have recognised the strengths of our
'Complete Connected Capital' model, investees, exit track record and the
excellence of the team we have built at Mercia.

Our performance, which has seen us return c.£280million to investors across
our collective asset classes since April 2020, will underpin our continuing
efforts to further grow AuM organically over the near-to-medium term.

The exits we have achieved from Mercia's direct investment portfolio have
yielded an average premium to holding value of c.53%. The table below shows
our performance since IPO, in terms of fully-realised exits. To date, every
full-cash exit has been above carrying value.

 Financial year exit/investee                      Carrying value      Realised value £'000      Premium

                                                   £'000                                         %
 2017
    Abzena plc                                     150                 170                       13.3
    Allinea Software Limited                       1,900               2,700                     42.1
 2018
    Science Warehouse Limited                      9,900               10,500                    6.1
 2021
    The Native Antigen Company Limited             3,500               5,200                     48.6
    Clear Review Limited                           1,030               1,040                     1.0
    Oxford Genetics Limited                        16,100              30,700                    90.7
 2022
    Faradion Limited                               12,900              19,400                    50.4
 Total/average premium                             45,480              69,710                    53.3

 

The table above demonstrates the value Mercia has created through its balance
sheet exits over time. This performance not only validates Mercia's
disciplined approach to valuation, but also points to the potential of future
net asset value increases from realisations over time.

With over a quarter of Mercia's AuM in unrestricted cash available for
investment, our reputation as a truly regional investor aligned with our
investees' growth aspirations, is aiding our deal sourcing and continues to be
a key competitive advantage. During this six-month period, we received 1,165
requests for investment and invested c.£56million into 80 businesses. This
investment cadence is critical to meeting our capital deployment targets
across both our debt and equity teams as we look to build out our portfolios
with new investments, during a period where value for a patient investor with
capital to deploy will become evident.

With the recent opening of our Bristol office and the acquisition of FDC
providing a central Birmingham location, we now have nine fully-staffed
offices across the UK plus two further satellite offices in Nottingham and
Hull. These offices provide us with reach across the entirety of England,
Scotland and Wales for deal origination and portfolio support. Following the
FDC acquisition, Mercia now has 144 employees and we continue to invest in our
talented team as we work together to deliver Mercia's '20:20' strategy. I am
proud of the diverse and inclusive culture at Mercia as we continue to operate
within our core values of trust, growth, knowledge and responsiveness, coupled
closely with our dedication to the UN Principles of Responsible Investment.

Outlook

Many businesses are facing national and global headwinds as we approach 2023.
This is arguably most acute in the technology sector and, specifically, within
capital-intensive, loss-making business-to-consumer companies. These headwinds
are particularly visible in the public markets. Against this backdrop Mercia
is well placed, especially given the significant liquidity we have to deploy
into what is a buyers' market.

With our focus on SMEs within the UK, predominantly businesses in sectors with
relatively modest capital needs, we and the funds we manage, are able to
continue to support these businesses with additional capital as and when
needed during these turbulent times. As almost all businesses in our
portfolios are private businesses, our exposure to the public markets is
limited. In addition, as a debt-free, cash-rich business, Mercia is well
placed to capitalise on both corporate (as evidenced by our recent
acquisition) and direct investment opportunities as we invest through the
cycle. A majority of the Group's investment realisations are through trade
sale exits (just two exits in the last two years were via IPOs), and this part
of the market remains relatively resilient.

I am sincerely grateful to all our employees, portfolio companies, managed
fund investors, our many other valued stakeholders and, of course, our
shareholders, for their continued commitment and belief in Mercia.

At this mid-point in our current three-year strategic plan, we remain
confident that we will deliver Mercia '20:20' by 31 March 2024.

Though the public markets may be stressed, Mercia is not.

 

Dr Mark Payton
Chief Executive Officer

 

 

Chief Investment Officer's review

Investment activity

During the six months to 30 September 2022, we invested c.£56million into 80
businesses across our funds and balance sheet. This included 34 companies new
to Mercia's third-party managed funds and one new direct investment portfolio
company, Uniphy. At the end of the period, we had c.£296million of liquidity
to support our future investment activity, including c.£56million on our
balance sheet, putting us in a strong position as we move towards 2023.
Overall, AuM increased c.2% to c.£979million, including positive direct
investment net fair value movements of £5.6million.

We have started to reap the benefits of our expanding regional footprint with
four new investments in the South West region, and see significant opportunity
in this vibrant part of the UK. It is due to the scale of the opportunity here
that we will soon be expanding our South West team to four full-time
investment professionals, based in Bristol.

Investment realisations

During the six-month period to 30 September 2022, we benefitted from 14 full
and partial equity exits (H1 2022: nine). These realised c.£25million at a
combined return of 1.6x. The standout exit was C7 Health Limited ("C7"), which
we sold in June to TAC Healthcare Limited ("TAC Healthcare"), generating a
c.14x cost return for our earliest EIS investors and a c.9x cost return for
subsequent fund investors. The overall blended cash-on-cash return was lower,
as nine businesses were exited at either less than investment cost or were
partial realisations. Within the management of venture portfolios, it is
crucial to alleviate investment management time from underperforming assets.
This discipline will continue as our portfolios mature and grow in size.

Proprietary capital

As at 30 September 2022, our direct investment portfolio was fair valued at
£131.5million (H1 2022: £110.3million; FY 2022: £119.6million) with 22
active companies (H1 2022: 20; FY 2022: 21).

We invested £6.4million net into the direct investment portfolio in the first
six months of the current financial year (H1 2022: £5.4million). A
significant amount of time was spent evaluating our new deal pipeline, which
resulted in a small initial investment into Uniphy, a Deep Tech business that
can enable any surface to become a smart human-machine interface. Our efforts
also saw us add two new direct investments shortly after the period end in
October 2022, with Axis Spine, a Med Tech business delivering spinal implants,
and Nova Pangaea, a Clean Tech business focused on creating biofuels and
biochar to address some of the most pressing climate concerns of today. The
investment into Axis Spine was part of a £10.0million series A round which
included other Mercia funds, as well as continuing our strategy of bringing in
specialist new syndicate partners, such as MedTex Ventures LLC from the USA, a
specialist healthcare investor.

The table below lists Mercia's top 20 investments by fair value as at 30
September 2022, including the net cash invested, realisation proceeds, fair
value movements and the fully diluted equity percentage held.

                               Year of             Net           Net cash        Investment      Fair value      Net

                               first               investment    invested        realisations    movement        investment     Percentage

                               direct investment   value as at   six months to   six months to   six months to   value as at    held as at

1 April
30 September

2022
               30 September    30 September    30 September   30 September

             2022

                                                   £'000
               2022            2022            2022           2022
                                                                 £'000

                                                                                 £'000           £'000           £'000          %
 nDreams Ltd                   2014                25,761        -               -               -               25,761         33.2
 Impression Technologies Ltd   2015                10,372        3,588           -               -               13,960         65.1
 Netacea Ltd                   2022                -             -               -               12,204          12,204         24.1
 Voxpopme Ltd                  2018                10,511        -               -               -               10,511         17.6
 VirtTrade Ltd *               2015                5,387         450             -               4,003           9,840          40.6
 Warwick Acoustics Ltd         2014                6,306         1,450           -               1,939           9,695          40.3
 Medherant Ltd                 2016                8,989         -               -               -               8,989          33.1
 Invincibles Studio Ltd        2015                4,600         -               -               1,400           6,000          39.0
 Ton UK Ltd **                 2015                6,074         -               -               (699)           5,375          29.9
 Locate Bio Ltd                2018                4,858         -               -               -               4,858          18.1
 Eyoto Group Ltd               2017                2,960         444             -               -               3,404          11.5
 Sense Biodetection Ltd        2020                2,479         -               -               -               2,479          1.6
 sureCore Ltd                  2016                2,417         -               -               -               2,417          22.0
 W2 Global Data Solutions Ltd  2018                2,500         200             -               (401)           2,299          16.3
 Intechnica Holdings Ltd ***   2017                14,411        -               -               (12,204)        2,207          24.1
 PsiOxus Therapeutics Ltd      2015                1,780         -               -               -               1,780          1.4
 Forensic Analytics Ltd        2021                1,750         -               -               -               1,750          8.9
 MyHealthChecked PLC           2016                1,632         -               -               102             1,734          13.1
 MIP Discovery Ltd             2020                1,449         -               -               -               1,449          10.2
 Edge Case Games Ltd           2015                2,300         -               -               (883)           1,417          18.7
 Other direct investments      n/a                 3,022         271             (11)            134             3,416          n/a
 Total                                             119,558       6,403           (11)            5,595           131,545        n/a

 

*      Trading as Avid Games

**          Trading as Intelligent Positioning

***  Formerly Intechnica Group Ltd prior to the demerger of Netacea Ltd

 

Direct investment portfolio highlights

The period under review saw net upward fair value movements of £5.6million,
mainly driven by significant commercial progress at our two mobile games
businesses, VirtTrade Limited ("VirtTrade") and Invincibles Studio Limited
("Invincibles Studio"), in addition to continued progress made by Warwick
Acoustics Limited ("Warwick Acoustics"). The significant fair value movement
shown above on Intechnica follows the demerger into separate entities of the
profitable Intechnica consultancy business and Netacea, the bot management
business; however if taken together, the aggregate carrying value of the two
businesses has not changed from that of the original Intechnica Group Limited
as at 31 March 2022. The other small fair value uplift arose as a result of
MyHealthChecked PLC's share price increase from 1.6 pence as at 31 March 2022,
to 1.7 pence as at 30 September 2022. These uplifts were balanced against
falls at our lower growth software businesses, Intelligent Positioning
Limited, W2 Global Data Solutions Limited, and digital games company Edge Case
Games Limited as expected royalty receipts from Wargaming move further out
into the future.

Our top 10 direct investment holdings represent c.82% of the value of our
portfolio as at 30 September 2022. There has been positive progress across a
number of our largest investments as summarised in the sectorial review below.

Digital Entertainment; c.33% by value of the portfolio

nDreams Limited ("nDreams"): 33.2% fully diluted direct investment

Farnborough-based nDreams achieved revenues of £5.6million for the year to 31
March 2022. Following the £20.0million investment from Aonic AB in March
2022, the company has significantly grown its workforce and capabilities. It
now has four teams working across three studios on different projects,
including a new remote team working on truly next-generation virtual reality
("VR") gaming concepts including Ghostbusters VR with Sony Pictures and Meta.
Its third-party publishing division continues to progress after the successful
launch of Little Cities in early 2022.

Mercia first supported nDreams in 2014 via its managed funds. The company is
highly regarded in the VR space as much for its technical capability in VR,
following the launch of its Fracked game, as for its quality content and
publishing success.

Invincibles Studio: 39.0% fully diluted direct investment stake with a further
7.6% fully diluted stake held by Mercia's managed funds

North West-based mobile soccer management game developer Invincibles Studio
continues to make steady progress. Its Soccer Manager 2023 game launch in late
September 2022 has resulted in significant growth, with new users up c.80% and
revenues up more than c.50%. Invincibles Studio has renewed its previously
negotiated licences with FIFPro, the Scottish Premier League, Arsenal football
club manager Mikel Arteta as the face of the game, and the social media rights
to Inter Milan. It has also signed a worldwide licence with the Bundesliga and
its players. Invincibles Studio has two new games in development which will be
launched in 2023. The first will be Ultimate Soccer League, a new multiplayer
game that will offer a differentiated experience from other football
management games, in Spring 2023.

VirtTrade: 40.6% fully diluted direct investment stake with a further 4.2%
fully diluted stake held by Mercia's managed funds

VirtTrade originally developed and operated a platform that enabled the rapid
creation, distribution and sale of digital trading cards across white-label
mobile applications. The business launched a mobile game using its own
intellectual property called 'CUE Cards' (Cards, the Universe and Everything)
in December 2019 and is now focused entirely on growing this game. VirtTrade
has been able to scale significantly over the past year, and has grown monthly
revenues five-fold, by focusing on the key metric of return on advertising
spend.

Software; c.27% by value of the portfolio

Voxpopme Limited ("Voxpopme"): 17.6% fully diluted direct investment stake
with a further 13.6% fully diluted stake held by Mercia's managed funds

Voxpopme is a software business based in Birmingham and Colorado USA that
provides video analytics software to firms in the market research, customer
experience and, in the future, the recruitment and HR markets. Its primary
business of video data analytics is proving disruptive to both the market
research and customer experience markets, where it has launched products to
date. Its annual recurring revenue ("ARR") has now grown to $8.4million.

Netacea: 24.1% fully diluted direct investment stake with a further 26.5%
fully diluted stake held by Mercia's managed funds

Manchester-based Netacea has developed an enterprise server-side bot
management solution that protects websites, mobile apps and APIs from
automated threats, using an intelligent detection engine. The agentless
technology focuses on understanding the traffic's intent rather than just
distinguishing between human and malicious bots. It is now a standalone entity
with an ARR of c.£6million, having demerged from Intechnica, and is
concentrating on scaling its sales and partnership business, both in the UK
and in the USA.

Deep Technology ("Deep Tech"); c.20% by value of the portfolio

Impression Technologies Limited ("ITL"): 65.1% fully diluted direct investment
stake with a further 0.9% fully diluted stake held by Mercia's managed funds

ITL has been developing a proprietary aluminium lightweight technology,
HFQ™, with its own pressing plant in Coventry, since 2016. Alongside its
German licensee, Fischer, it recently showcased the world's first example of
an HFQ-formed high-strength aluminium structure using 100% recycled aluminium
(having the potential to reduce embedded carbon by over 90%). In addition, ITL
presented an innovative single-piece battery enclosure lid made from
high-strength alloy. As an innovation that could offer reduced weight, part
count and carbon intensity, HFQ captured the attention of a large number of
engineers from established and emerging original equipment manufacturers
("OEMs"), with a focus on new electric vehicle and delivery van platforms.

Warwick Acoustics: 40.3% fully diluted direct investment stake with a further
1.3% fully diluted stake held by Mercia's managed funds

Midlands-based Warwick Acoustics creates highly innovative audio products for
both the automotive and the high-end personal and studio headphone market. The
company raised a further £2.5million in the summer from new and existing
shareholders to fund its next stage of development. Commercial traction
continues with three ongoing projects at various stages with global automotive
OEMs and with others under current negotiation.

Life Sciences; c.20% by value of the portfolio

Medherant Limited ("Medherant"): 33.1% fully diluted direct investment stake
with a further 13.1% fully diluted stake held by Mercia's managed funds

Midlands-based Medherant is a University of Warwick spinout commercialising a
platform of proprietary patch adhesive for medical applications. It benefits
from several external partnerships and its internal development program is
progressing well ahead of a potential late-2023 launch. In respect of its
external partnerships, one has progressed through the first two evaluation
hurdles, with the collaboration having been extended further. If successful,
this would address a multi-billion-dollar market opportunity.

Locate Bio Limited ("Locate Bio"): 18.1% fully diluted direct investment stake
with a further 24.6% fully diluted stake held by Mercia's managed funds

Nottingham-based Locate Bio is developing a range of orthobiologics, including
its lead bone graft solution which continues its large trials program as part
of the US Food and Drug Administration approval process. Locate Bio's products
will be used by orthopaedic surgeons to accelerate the natural repair of bone
and cartilage. Addressing a multi-billion-pound global market, Locate Bio
currently has four products going through trials.

Assets under management

AuM increased by c.2% to c.£979million, with c.£54million of new capital
raised by our retail EIS and Northern VCTs during the six-month period.
Partially offsetting these AuM inflows were downward valuation movements in
AIM- quoted VCT portfolio companies, the largest being musicMagpie plc, in
addition to distributions back to fund investors and dividends paid to VCT and
Mercia shareholders.

                      AuM       Investor  Performance  Distributions  AuM            Post

                      1 April   inflows                               30 September   period end

                      2022                                            2022           inflows
 Asset class          £'m       £'m       £'m          £'m            £'m            £'m
 Venture              592       54        (21)         (14)           611            12
 Private equity       48        -         (2)          -              46             -
 Debt                 118       -         -            (2)            116            -
 Total FuM            758       54        (23)         (16)           773            12
 Proprietary capital  201       -         7            (2)            206            -
 Total AuM            959       54        (16)         (18)           979            12

 

Third-party managed funds

As at 30 September 2022, we were managing c.£773million of third-party funds
(H1 2022: c.£762million; FY 2022: c.£758million). Across those funds we had
c.£240million of liquidity (H1 2022: c.£232million; FY 2022:
c.£236million), which enables us to fully support our portfolio companies and
transact new deals in the future.

In April 2022, we added a further c.£45million of organic FuM following
successful EIS and Northern VCT fundraises, and in September 2022, closed our
Q3 2022 EIS Fund, raising c.£9million. Furthermore, post period end, we have
received a further c.£12million allocation from the BBB in relation to our
MEIF mandate.

During the six-month period ended 30 September 2022, we invested £49.1million
across the multiple funds which we manage as follows:

                   FuM

                   30 September   Companies      Amount     Company

                   2022           in portfolio   invested   exits

 Asset class       £'m            No.            £'m        No.
 EIS               89              71            5.8        5
 VCT               335            56             20.2       2
 Regional venture  187            109            13.1       6
 Private equity    46             9              0.3        -
 Debt              116            179            9.7        16
 Totals            773            424            49.1       29

Managed funds' portfolios

Venture

The 13 full and partial exits returned £25.0million in the six months to 30
September 2022, at a combined return of 1.6x. The standout exit was C7, which
we sold in June to TAC Healthcare, generating proceeds of £8.0million,
equating to a return of c.14x cost for our earliest EIS investors and c.9x
cost for subsequent fund investors. Our VCTs exited two investments;
AIM-quoted Ideagen PLC, which has been held since its listing, generating a
return of 5.9x cost, and Edtech business, Knowledgemotion Limited, which
returned 1.7x cost.

Our third-party managed funds across all asset classes have exposure to
various technology sectors, but do not typically invest in capital-intensive
businesses or pre-IPO scale-ups hoping to list before reaching profitability
and cash generation.

Private equity ("PE")

The value of our PE funds declined marginally during the six months to 30
September 2022. Although Shoppertainment Limited and ParkVia Limited,
previously exposed to COVID-19-related issues, returned to growth, supply
chain headwinds and inflationary pressures continued to impact the portfolio.

Debt

Mercia's Debt funds' team saw an increase in activity during the period,
supporting 33 businesses, lending a total of £9.7million. In August 2022,
Mercia gained accreditation to deliver loans under phase three of the
Government's RLS, via its Northern Powerhouse Investment Fund debt mandate.
Mercia's vastly experienced Debt team continues to support profitable SMEs,
mainly across the North of England.

Summary

Only six months ago, I finished my Chief Investment Officer's review for the
year to 31 March 2022, saying that we must not ignore the effects of
inflation, ongoing supply chain issues and the uncertainty caused by military
conflict. We are now seeing the effects of all of these, alongside additional
political and mortgage rate instability, within our daily lives. This has
meant that we find ourselves in quite remarkable times. In contrast, the past
six months at Mercia have been relatively unremarkable; our experienced team
has been well prepared and our investee companies have put their heads down
and got on with what is in front of them. We continually review cash levels at
our investees and believe that their management teams work best when they are
not looking over their shoulders. We have ample cash on our balance sheet and
liquidity within our third-party funds to continue to support the most
promising investments over the next 12 months and beyond.

The beauty of our model at Mercia is that we can also provide significant
non-financial support to our companies, with value enhancing input from our
Head of Portfolio Resourcing, Lisa Ward, and her team. Within our network of
over 1,000 experienced NEDs, chairs and operating partners, there are
complementary skill sets that we can introduce to help our portfolio
businesses grow or navigate speed bumps; in the first six months we have made
16 such additional appointments.

The first half of the financial year has yielded continued progress across our
portfolio companies despite toughening conditions. As always, I would like to
thank all our dedicated staff for their efforts during the past six months.

 

Julian Viggars

Chief Investment Officer

 

 

 

Chief Financial Officer's review

Overall financial performance

Mercia has maintained positive financial momentum during the first half of the
current financial year, with increases in adjusted operating profit, net
assets and net assets per share.

Interim dividend

The Board adopted Mercia's progressive dividend policy in December 2020, and
since then has announced interim dividends of 0.10 pence per share in December
2020 and 0.30 pence per share in December 2021. Shareholders also approved a
maiden final dividend of 0.30 pence per share in September 2021 and 0.50 pence
per share in September 2022.

Given the Group's twin sources of profitability and cash inflow, being
regionally focused proactive specialist asset management, plus direct
investment and periodic cash realisations, the Group's dividend policy does
not need to be anchored to one or other source of liquidity, hence the Board's
intention to grow total dividends year on year.

The continuing positive overall Group performance, coupled with its future
prospects, has enabled Mercia's Board to declare an interim dividend of 0.33
pence per share (H1 2022: 0.30 pence per share). The interim dividend will be
paid on 4 January 2023 to shareholders on the register at close of business on
16 December 2022, with the total dividend payable being £1,452,000 (H1 2022:
£1,320,500).

Adjusted operating profit

The Directors believe that the reporting of adjusted operating profit assists
in providing a consistent measure of operating performance for businesses such
as Mercia and is an important alternative performance measure ("APM") of
interest to shareholders.

Adjusted operating profit is defined as operating profit before net
exceptional performance fees, realised gains on disposal of investments, fair
value movements in investments, share-based payments charge, depreciation,
amortisation of intangible assets, movement in fair value of deferred
consideration and exceptional items. It includes net finance income.

Results reported on an APM basis are denoted by ¹ throughout this review.

                                                              Unaudited          Unaudited          Audited

                                                              Six months ended   Six months ended   Year

                                                              30 September       30 September       ended

                                                              2022               2021               31 March

                                                              £'000              £'000              2022

                                                                                                    £'000
 Revenue                                                      12,181             10,089             20,576
 Administrative expenses                                      (10,102)           (7,957)            (16,618)
 Net finance income                                           1,480              230                4,437
 Adjusted operating profit(1)                                 3,559              2,362              8,395
 Net exceptional performance fees                             -                  1,592              1,592
 Adjusted operating profit(1) including net performance fees  3,559              3,954              9,987
 Depreciation                                                 (120)              (110)              (224)
 Net finance income                                           (1,480)            (230)              (4,437)
 Realised gain on disposal of investment                      -                  -                  9,878
 Fair value movements in investments                          5,595              8,708              11,385
 Share-based payments charge                                  (592)              (573)              (1,109)
 Amortisation of intangible assets                            (1,017)            (1,017)            (2,033)
 Movement in fair value of deferred consideration             -                  -                  (522)
 Operating profit                                             5,945              10,732             22,925
 Net finance income                                           1,480              230                4,437
 Profit before taxation                                       7,425              10,962             27,362
 Taxation                                                     (422)              192                (1,262)
 Profit and total comprehensive income                        7,003              11,154             26,100

 

A reconciliation of these interim results prepared in accordance with
International Financial Reporting Standards ("IFRS") to those presented on an
APM basis are as follows:

                                     Six-month period ended 30 September 2022
                          IFRS as reported      Performance fees  Depreciation  APM basis(1)
                          £'000                 £'000             £'000         £'000
 Revenue                  12,181                -                 -             12,181
 Administrative expenses  (10,222)              -                 120           (10,102)
 Depreciation             -                     -                 (120)         (120)

 

                          Six-month period ended 30 September 2021
                          IFRS as reported  Performance fees  Depreciation  APM basis(1)
                          £'000             £'000             £'000         £'000
 Revenue                  12,696            (2,607)           -             10,089
 Administrative expenses  (9,082)           1,015             110           (7,957)
 Depreciation             -                 -                 (110)         (110)

 

                          Year ended 31 March 2022
                          IFRS as reported  Performance fees  Depreciation  APM basis(1)
                          £'000             £'000             £'000         £'000
 Revenue                  23,183            (2,607)           -             20,576
 Administrative expenses  (17,857)          1,015             224           (16,618)
 Depreciation             -                 -                 (224)         (224)

 

Revenue

Revenue(1) increased 20.7% to £12,181,000 (H1 2022: £10,089,000) and
comprised fund management related fees, initial management fees from
investment rounds, investment director monitoring fees and sundry business
services income. Excluding the impact of April 2022's VCT share offer fees
received during the period, the like-for-like increase was c.8%.

For the prior interim period to 30 September 2021, revenue included a
£2.6million exceptional performance fee from Northern Venture Trust PLC.

Administrative expenses

Administrative expenses(1), excluding depreciation, increased 27.0% to
£10,102,000 (H1 2022: £7,957,000) and comprised predominantly staff-related,
office, marketing and professional adviser costs. Removing the impact of April
2022's VCT share offer related costs, the like-for-like increase was c.11%,
reflecting the post-COVID catch-up in staff recruitment together with
inflation.

For the prior interim period to 30 September 2021, administrative expenses
included variable compensation totalling £1.0million paid to members of
Mercia's VCT investment team, in connection with the exceptional performance
fee received.

Mercia anticipates that the financial benefits of operational leverage will
continue to be realised as its funds under management increase, by both its
organic and inorganic initiatives.

Net finance income

Total gross finance income of £1,488,000 (H1 2022: £238,000) arose primarily
from the crystallisation of convertible loan interest within the direct
portfolio. Gross finance income includes £117,000 (H1 2022: £3,000) of
interest received on cash deposits following Bank of England base rate rises
during the period. Finance costs of £8,000 (H1 2022: £8,000) comprised
interest payable on office leases and the Group's new electric car scheme.

Fair value movements in investments

                                                                 Unaudited          Unaudited          Audited

                                                                 Six months ended   Six months ended   Year

                                                                 30 September       30 September       ended

                                                                 2022               2021               31 March

                                                                 £'000              £'000              2022

                                                                                                       £'000
 Investment movements excluding cash invested and realisations:
 Unrealised gains on the revaluation of investments*             7,578              11,417             15,122
 Unrealised losses on the revaluation of investments*            (1,983)            (2,709)            (3,737)
 Net fair value movement                                         5,595              8,708              11,385

* Excluding the demerger of Netacea Limited from Intechnica Holdings Limited
in the period

 

Net fair value increases during the period totalled £5,595,000 (H1 2022:
£8,708,000) and as at 30 September 2022, the fair value of the Group's direct
investment portfolio was £131,545,000 (H1 2022: £110,298,000; FY 2022:
£119,558,000).

For the period as a whole, unrealised fair value gains arose in four* (H1
2022: eight) of the Group's direct investments. The largest fair value gain
was in respect of VirtTrade Limited, which accounted for £4,003,000 of the
total (H1 2022: £5,756,000 fair value gain in respect of Faradion Limited).

There were three* (H1 2022: two) fair value decreases, the largest being
£883,000 which arose in respect of Edge Case Games Limited (H1 2022:
£2,448,000 fair value decrease in MyHealthChecked PLC).

Share-based payments charge

The £592,000 non-cash charge (H1 2022: £573,000) arises from the net
increase in the total number of issued share options held by all employees
throughout the Group, ranging from 28 January 2020 to 30 September 2022.

Amortisation of intangible assets

The amortisation charge for the period of £1,017,000 (H1 2022: £1,017,000)
represents amortisation of the acquired intangible assets of the VCT fund
management business.

Taxation

The components of the Group's tax charge are shown in note 9. The overall tax
charge for the period comprises a corporation tax charge on taxable profits,
offset by the continued unwinding of the deferred tax liability in respect of
the intangible assets arising on the acquisition of the VCT fund management
business.

Profit and total comprehensive income for the period

The adjusted operating profit and net fair value increases for the period
contributed positively to a consolidated total comprehensive income of
£7,003,000 (H1 2022: £11,154,000). This has resulted in basic earnings per
Ordinary share of 1.59 pence (H1 2022: 2.53 pence).

Summarised statement of financial position and cash flows

                                                        Unaudited      Unaudited      Audited

                                                        As at          As at          As at

                                                        30 September   30 September   31 March

                                                        2022           2021           2022

                                                        £'000          £'000          £'000
 Goodwill and intangible assets                         31,338         33,371         32,355
 Direct investment portfolio                            131,545        110,298        119,558
 Other non-current assets, trade and other receivables  1,626          5,077          1,604
 Cash and short-term liquidity investments              56,112         52,114         61,284
 Total assets                                           220,621        200,860        214,801
 Trade and other payables                               (8,092)        (6,805)        (7,415)
 Deferred consideration                                 (2,869)        (4,447)        (2,869)
 Deferred taxation                                      (3,676)        (3,180)        (3,928)
 Total liabilities                                      (14,637)       (14,432)       (14,212)
 Net assets                                             205,984        186,428        200,589
 Net assets per share (pence) **                        46.8p          42.4p          45.6p

 

** 440,109,707 Ordinary shares were in issue during the six-month period ended
30 September 2022 and 30 September 2021, and the year ended 31 March 2022

 

Net assets per share increased by c.3% during the interim period,
notwithstanding the recognition of dividends totalling £2,200,000 paid after
the period end (H1 2022: c.6% growth after recognising dividends of
£1,320,500, paid after that period end).

Intangible assets

The Group's intangible assets consist of goodwill and the intangible asset
recognised on the acquisition of the VCT fund management business.

Direct investment portfolio

During the period, Mercia's direct investment portfolio grew from
£119,558,000 as at 1 April 2022 (H1 2022: £96,220,000 as at 1 April 2021) to
£131,545,000 as at 30 September 2022 (H1 2022: £110,298,000 as at 30
September 2021), a c.10% increase (H1 2022: c.15% increase).

The Group invested £6,403,000 net (H1 2022: £5,370,000) into five existing
and one new direct investment, Uniphy Limited (H1 2022: five existing and no
new direct investments), with the top 20 direct investments representing 97.4%
of the total direct investment portfolio value (H1 2022: 98.5%; FY 2022:
98.6%).

Cash and short-term liquidity investments

At the period end, Mercia had cash and short-term liquidity investments (which
is cash on deposit with maturities of between 32 days and three months)
totalling £56,112,000 (H1 2022: £52,114,000; FY 2022: £61,284,000),
comprising cash of £50,864,000 (H1 2022: £51,880,000; FY 2022: £56,049,000)
and short-term liquidity investments of £5,248,000 (H1 2022: £234,000; FY
2022: £5,235,000).

The Group continues to have limited working capital needs due to the nature of
its business and during the six-month period generated operating cash inflow
of £0.5million (H1 2022: £2.6million inflow).

The overriding emphasis of the Group's treasury policy remains the
preservation of its shareholders' cash for investment, corporate and working
capital purposes, not yield. As at 30 September 2022, the Group's cash and
short-term liquidity investments were spread across four leading United
Kingdom banks.

The summarised movements in the Group's cash and short-term liquidity
investments during the period are shown below.

                                                                     Unaudited          Unaudited          Audited

                                                                     Six months ended   Six months ended   Year

                                                                     30 September       30 September       ended

                                                                     2022               2021               31 March

                                                                     £'000              £'000              2022

                                                                                                           £'000
 Opening cash and short-term liquidity investments                   61,284             54,725             54,725
 Cash generated from operating activities                            544                2,625              9,150
 Corporation tax paid                                                (705)              -                  -
 Net cash (used in)/generated from direct investment activities      (5,021)            (5,135)            2,363
 Purchase of VCT fund management contracts (deferred consideration)  -                  -                  (2,100)
 Cash inflow/(outflow) from other investing activities               97                 (31)               (62)
 Net cash used in financing activities                               (87)               (70)               (2,792)
 Closing cash and short-term liquidity investments                   56,112             52,114             61,284

 

Outlook

Investing in young technology businesses or lending to more established SMEs
is rarely a linear journey at times of economic instability, such as now.
During such times, the continuing availability of cash to those businesses
provides the 'oxygen' that they need to execute their long-term growth plans,
uninterrupted by near-term cash crunches. As a direct consequence of the
significant liquidity held in both our funds under management and on our own
balance sheet, Mercia is able to continue to support those businesses without
hindering both pillars of its own organic and inorganic growth strategy.

Having successfully grown revenues, profits, cash and NAV per share during the
pandemic, Mercia is now navigating this period of significant economic and
geopolitical uncertainty, elevated inflation and a downturn in sentiment
towards the tech sector, from the fortunate position of debt-free strength.

The Group's excellent staff, supportive stakeholders, strong liquidity,
increasing funds under management and growing direct investment portfolio,
should enable the Group to remain on track with its Mercia '20:20' strategy
through to 31 March 2024.

 

Martin Glanfield

Chief Financial Officer

 

 

Summary Financial Information

Condensed consolidated statement of comprehensive income

For the six months ended 30 September 2022

                                                       Note  Unaudited          Unaudited          Audited

                                                             Six months ended   Six months ended   Year

                                                             30 September       30 September       ended

                                                             2022               2021               31 March

                                                             £'000              £'000              2022

                                                                                                   £'000
 Revenue                                               5     12,181             12,696             23,183
 Administrative expenses                               7     (10,222)           (9,082)            (17,857)
 Realised gain on sale of direct investment                  -                  -                  9,878
 Fair value movements in direct investments            12    5,595              8,708              11,385
 Share-based payments charge                                 (592)              (573)              (1,109)
 Amortisation of intangible assets                           (1,017)            (1,017)            (2,033)
 Movement in fair value of deferred consideration            -                  -                  (522)
 Operating profit                                            5,945              10,732             22,925
 Finance income                                        8     1,488              238                4,452
 Finance expense                                             (8)                (8)                (15)
 Profit before taxation                                      7,425              10,962             27,362
 Taxation                                              9     (422)              192                (1,262)
 Profit and total comprehensive income for the period        7,003              11,154             26,100
 Basic earnings per Ordinary share (pence)             10    1.59               2.53               5.93
 Diluted earnings per Ordinary share (pence)           10    1.57               2.50               5.82

 

All results derive from continuing operations.

 

Condensed consolidated statement of financial position

As at 30 September 2022

                                   Note  Unaudited      Unaudited      Audited

                                         As at          As at          As at

                                         30 September   30 September   31 March

                                         2022           2021           2022

                                         £'000          £'000          £'000
 Assets
 Non-current assets
 Goodwill                                16,642         16,642         16,642
 Intangible assets                       14,696         16,729         15,713
 Property, plant and equipment           101            105            113
 Right-of-use assets                     367            421            417
 Investments                       12    131,545        110,298        119,558
 Total non-current assets                163,351        144,195        152,443
 Current assets
 Trade and other receivables             1,158          4,551          1,074
 Short-term liquidity investments  13    5,248          234            5,235
 Cash and cash equivalents         13    50,864         51,880         56,049
 Total current assets                    57,270         56,665         62,358
 Total assets                            220,621        200,860        214,801
 Current liabilities
 Trade and other payables                (7,683)        (6,355)        (6,963)
 Lease liabilities                       (168)          (131)          (157)
 Deferred consideration            14    (2,869)        (1,578)        (2,869)
 Total current liabilities               (10,720)       (8,064)        (9,989)
 Non-current liabilities
 Lease liabilities                       (241)          (319)          (295)
 Deferred consideration            14    -              (2,869)        -
 Deferred taxation                 15    (3,676)        (3,180)        (3,928)
 Total non-current liabilities           (3,917)        (6,368)        (4,223)
 Total liabilities                       (14,637)       (14,432)       (14,212)
 Net assets                              205,984        186,428        200,589
 Equity
 Issued share capital                    4              4              4
 Share premium                           81,644         81,644         81,644
 Other distributable reserve       16    64,719         68,240         66,919
 Retained earnings                       55,508         33,559         48,505
 Share-based payments reserve            4,109          2,981          3,517
 Total equity                            205,984        186,428        200,589

 

The accompanying notes are an integral part of these condensed consolidated
interim financial statements.

 

The condensed consolidated interim financial statements of Mercia Asset
Management PLC were approved by the Board of Directors on 5 December 2022 and
authorised for issue. They were signed on its behalf by:

 

 

Dr Mark Payton                               Martin Glanfield

Chief Executive Officer                   Chief Financial
Officer

 

Condensed consolidated statement of cash flows

For the six months ended 30 September 2022

                                                                             Note  Unaudited          Unaudited          Audited

                                                                                   Six months ended   Six months ended   Year

                                                                                   30 September       30 September       ended

                                                                                   2022               2021               31 March

                                                                                   £'000              £'000              2022

                                                                                                                         £'000
 Cash flows from operating activities:
 Operating profit                                                                  5,945              10,732             22,925
 Adjustments to reconcile operating profit to cash generated from operating
 activities:
 Depreciation of property, plant and equipment                                     32                 36                 70
 Depreciation of right-of-use assets                                               88                 74                 154
 Gain on sale of direct investment                                                 -                  -                  (9,878)
 Fair value movements in direct investments                                  12    (5,595)            (8,708)            (11,385)
 Share-based payments charge                                                       592                573                1,109
 Amortisation of intangible assets                                                 1,017              1,017              2,033
 Movement in fair value of contingent consideration                                -                  -                  522
 Working capital adjustments:
 (Increase)/decrease in trade and other receivables                                (84)               (491)              2,986
 (Decrease)/increase in trade and other payables                                   (1,451)            (608)              614
 Cash generated from operating activities                                          544                2,625              9,150
 Corporation tax paid                                                              (705)              -                  -
 Net cash (used in)/generated from operating activities                            (161)              2,625              9,150
 Cash flows from direct investment activities:
 Sale of direct investments                                                  12    11                 -                  16,309
 Purchase of direct investments                                              12    (6,403)            (5,370)            (19,884)
 Investee company loan repayment                                             12    -                  -                  1,500
 Investee company loan redemption premiums and interest received             8     1,371              235                4,438
 Net cash (used in)/generated from direct investment activities                    (5,021)            (5,135)            2,363
 Cash flows from other investing activities:
 Receipt of bank interest on deposits                                              104                3                  14
 Purchase of property, plant and equipment                                         (20)               (34)               (76)
 Purchase of VCT fund management contracts                                         -                  -                  (2,100)
 Increase in short-term liquidity investments                                      -                  -                  (5,001)
 Net cash generated from/(used in) other investing activities                      84                 (31)               (7,163)
 Net cash used in total investing activities                                       (4,937)            (5,166)            (4,800)
 Cash flows from financing activities:
 Dividends paid                                                              11    -                  -                  (2,641)
 Interest paid                                                                     (8)                (8)                (15)
 Payment of lease liabilities                                                      (79)               (62)               (136)
 Net cash used in financing activities                                             (87)               (70)               (2,792)
 Net (decrease)/increase in cash and cash equivalents                              (5,185)            (2,611)            1,558
 Cash and cash equivalents at the beginning of the period                          56,049             54,491             54,491
 Cash and cash equivalents at the end of the period                          13    50,864             51,880             56,049

 

Condensed consolidated statement of changes in equity

For the six months ended 30 September 2022

                                                       Issued    Share     Other           Retained   Share-based  Total

                                                       share     premium   distributable   earnings   payments     £'000

                                                       capital   £'000     reserve         £'000      reserve

                                                       £'000               £'000                      £'000
 As at 1 April 2021 (audited)                          4         81,644    69,560          22,405     2,408        176,021
 Profit and total comprehensive income for the period  -         -         -               11,154     -            11,154
 Final dividend                                        -         -         (1,320)         -          -            (1,320)
 Share-based payments charge                           -         -         -               -          573          573
 As at 30 September 2021 (unaudited)                   4         81,644    68,240          33,559     2,981        186,428
 Profit and total comprehensive income for the period  -         -         -               14,946     -            14,946
 Interim dividend                                      -         -         (1,321)         -          -            (1,321)
 Share-based payments charge                           -         -         -               -          536          536
 As at 31 March 2022 (audited)                         4         81,644    66,919          48,505     3,517        200,589
 Profit and total comprehensive income for the period  -         -         -               7,003      -            7,003
 Final dividend                                        -         -         (2,200)         -          -            (2,200)
 Share-based payments charge                           -         -         -               -          592          592
 As at 30 September 2022 (unaudited)                   4         81,644    64,719          55,508     4,109        205,984

 

1. General information

Mercia Asset Management PLC is a public limited company incorporated and
domiciled in England, United Kingdom and registered
in England and Wales with registered number 09223445. Its Ordinary shares
are admitted to trading on the Alternative Investment Market ("AIM") of the
London Stock Exchange. The registered office address is Mercia Asset
Management PLC, Forward House, 17 High Street, Henley-in-Arden B95 5AA.

2. Basis of preparation

The financial information presented in these condensed consolidated interim
financial statements constitutes the condensed consolidated financial
statements of Mercia Asset Management PLC and its subsidiaries for the six
months ended 30 September 2022. These condensed consolidated interim financial
statements should be read in conjunction with the Group's Annual Report and
consolidated financial statements for the year ended 31 March 2022, which have
been prepared in accordance with international accounting standards in
conformity with the requirements of the Companies Act 2006, International
Financial Reporting Standards ("IFRS"), and the applicable legal requirements
of the Companies Act 2006.

These condensed consolidated interim financial statements and the comparative
financial information presented in these condensed consolidated interim
financial statements for the period ended 30 September 2022 do not constitute
full statutory accounts within the meaning of Section 434 of the Companies Act
2006. The Group's Annual Report and consolidated financial statements for the
year ended 31 March 2022 were approved by the Board on 4 July 2022 and have
been delivered to the Registrar of Companies. The Group's independent
auditor's report on those accounts was unqualified, did not contain an
emphasis of matter paragraph and did not contain any statement under section
498 of the Companies Act 2006.

These condensed consolidated interim financial statements have been prepared
in accordance with International Accounting Standard ("IAS") 34 'Interim
Financial Reporting', as adopted for use in the UK.

No new or revised standards or interpretations that have become effective
during the period ended 30 September 2022 have had a material effect on the
financial statements of the Group.

Although not required by statute or regulation, the financial information
contained in these condensed consolidated interim financial statements, which
were approved by the Board on 5 December 2022 and authorised for issue, have
been reviewed by the Group's independent auditor.

3. Going concern

Based on the overall strength of the Group's financial position, including its
significant liquidity at the period end, together with its forecast future
operating and investment activities and, having considered the ongoing UK
macroeconomic backdrop, geopolitical instability and the war in Ukraine on the
Group's operations and portfolio, the Directors have a reasonable expectation
that the Group is well placed to manage business risks in the current economic
environment and has adequate financial resources to continue in operational
existence for the foreseeable future. Accordingly, the Directors continue to
adopt the going concern basis in preparing these condensed consolidated
interim financial statements.

4. Significant accounting policies

In the application of the Group's accounting policies, the Directors are
required to make judgements, estimates and assumptions about the carrying
amounts of assets and liabilities that are not readily apparent from other
sources. The estimates and associated assumptions are based on historical
experience and other factors that are considered to be relevant. Actual
results may differ from these estimates. The estimates and underlying
assumptions are reviewed on an ongoing basis. Revisions to accounting
estimates are recognised in the period in which the estimate is revised if the
revision affects only that period, or in the period of the revision and future
periods if the revision affects both current and future periods.

The principal accounting policies applied in the presentation of the condensed
consolidated interim financial statements of Mercia Asset Management PLC (the
"Group", "Mercia" or the "Company"), including the critical accounting
judgements made by the Directors and the key sources of estimation, are
consistent with those followed in the preparation of the Group's Annual Report
and consolidated financial statements for the year ended 31 March 2022, and
have been consistently applied throughout the period ended 30 September 2022.

5. Segmental reporting

The Group's revenue and profits are derived from its principal activity within
the United Kingdom.

IFRS 8 Operating Segments defines operating segments as those activities of an
entity about which separate financial information is available and which are
evaluated by the Chief Operating Decision Maker to assess performance and
determine the allocation of resources. The Chief Operating Decision Maker has
been identified as the Board of Directors. The Directors are of the opinion
that under IFRS 8 Operating Segments the Group has only one operating segment,
being proactive specialist asset management, because the results of the Group
are monitored on a Groupwide basis. The Board of Directors assesses the
performance of the operating segment using financial information which is
measured and presented in a consistent manner.

An analysis of the Group's revenue is as follows:

                            Unaudited          Unaudited          Audited

                            Six months ended   Six months ended   Year

                            30 September       30 September       ended

                            2022               2021               31 March

                            £'000              £'000              2022

                                                                  £'000
 Fund management fees       8,469              7,385              14,957
 Initial management fees    890                1,113              2,456
 Portfolio directors' fees  1,351              1,500              2,969
 Other revenue              140                91                 194
 VCTs share offer fees      1,331              -                  -
 Performance fees           -                  2,607              2,607
                            12,181             12,696             23,183

6. Fair value movements in investments

                                                    Unaudited          Unaudited          Audited

                                                    Six months ended   Six months ended   Year

                                                    30 September       30 September       ended

                                                    2022               2021               31 March

                                                    £'000              £'000              2022

                                                                                          £'000
 Net fair value movements in investments (note 12)  5,595              8,708              11,385

7. Operating profit

Operating profit is stated after charging:

                                                                           Unaudited          Unaudited          Audited

                                                                           Six months ended   Six months ended   Year

                                                                           30 September       30 September       ended

                                                                           2022               2021               31 March

                                                                           £'000              £'000              2022

                                                                                                                 £'000
 Staff costs (including variable compensation linked to performance fees)  6,743              6,460              12,961
 Other administrative expenses                                             3,479              2,622              4,896
 Total administrative expenses                                             10,222             9,082              17,857

8. Finance income

Finance income is derived from:

                                                            Unaudited          Unaudited          Audited

                                                            Six months ended   Six months ended   Year

                                                            30 September       30 September       ended

                                                            2022               2021               31 March

                                                            £'000              £'000              2022

                                                                                                  £'000
 Cash and cash equivalents                                  104                3                  12
 Short-term liquidity investments                           13                 -                  2
 Investee company loans (interest and redemption premiums)  1,371              235                4,438
 Total finance income                                       1,488              238                4,452

9. Taxation

                                                           Unaudited          Unaudited          Audited

                                                           Six months ended   Six months ended   Year

                                                           30 September       30 September       ended

                                                           2022               2021               31 March

                                                           £'000              £'000              2022

                                                                                                 £'000
 Current tax
 UK Corporation tax                                        (674)              -                  (706)
 Deferred tax
 Origination and reversal of temporary timing differences  252                192                508
 Effects of changes in tax rates                           -                  -                  (1,064)
 Total tax (charge)/credit                                 (422)              192                (1,262)

The current UK standard rate of corporation tax is 19% (H1 2022: 19%). The
deferred tax credit of £252,000 (H1 2022: £192,000) represents the unwinding
of the deferred tax liability recognised in respect of the intangible assets
arising on the acquisition of the VCT fund management business.

10. Earnings per share

Basic earnings per share is calculated by dividing the profit for the
financial period by the weighted average number of Ordinary shares in issue
during the period. Diluted earnings per share is calculated by dividing the
profit for the financial period by the weighted average number of Ordinary
shares outstanding and, when dilutive, adjusted for the effect of all
potentially dilutive shares including share options on an as-if-converted
basis. The potential dilutive shares are included in diluted earnings per
share calculations on a weighted average basis for the period. The profit and
weighted average number of shares used in the calculations are set out below:

                                                            Unaudited          Unaudited          Audited

                                                            Six months ended   Six months ended   Year

                                                            30 September       30 September       ended

                                                            2022               2021               31 March

                                                                                                  2022
 Profit for the financial period (£'000)                    7,003              11,154             26,100
 Basic weighted average number of Ordinary shares ('000)    440,110            440,110            440,110
 Basic earnings per Ordinary share (pence)                  1.59               2.53               5.93
 Diluted weighted average number of Ordinary shares ('000)  447,216            447,028            448,466
 Diluted earnings per Ordinary share (pence)                1.57               2.50               5.82

The calculation of basic and diluted earnings per share is based on the
following weighted average number of Ordinary shares:

                                                     Unaudited          Unaudited          Audited

                                                     Six months ended   Six months ended   Year

                                                     30 September       30 September       ended

                                                     2022               2021               31 March

                                                                                           2022
 Weighted average number of shares
 Basic                                               440,110            440,110            440,110
 Dilutive impact of Ordinary shares issued           7,106              6,918              8,356
 Diluted weighted average number of Ordinary shares  447,216            447,028            448,466

11. Dividends

In October 2021, the Company paid £1,320,500 in respect of its maiden final
dividend for the year ended 31 March 2021 of 0.30 pence per share.

In December 2021, the Company paid £1,320,500 in respect of its interim
dividend for the year ended 31 March 2022 of 0.30 pence per share.

The final dividend for the year ended 31 March 2022 of 0.50 pence per share,
totalling £2,200,500, was approved by shareholders at the Annual General
Meeting on 13 September 2022 and was paid after the period end, on 11 October
2022.

An interim dividend for the year ending 31 March 2023 of 0.33 pence per share,
totalling £1,452,000, has been declared after the reporting period end and as
such has not been included as a liability in these condensed consolidated
financial statements, in accordance with IAS 10.

12. Investments

The net change in the value of investments for the six-month period is an
increase of £11,987,000 (H1 2022: £14,078,000). The table below reconciles
the opening to closing fair value of investments.

                                               Level 1     Level 3     Total

                                               financial   financial   financial

                                               assets      assets      assets
                                               £'000       £'000       £'000
 As at 1 April 2021 (audited)                  4,488       91,732      96,220
 Investments made during the period            -           5,370       5,370
 Unrealised fair value gains on investments    -           11,417      11,417
 Unrealised fair value losses on investments   (2,448)     (261)       (2,709)
 As at 30 September 2021 (unaudited)           2,040       108,258     110,298
 Investments made during the period            -           14,514      14,514
 Investee company loan repayment               -           (1,500)     (1,500)
 Disposal                                      -           (6,431)     (6,431)
 Unrealised fair value gains on investments    -           3,705       3,705
 Unrealised fair value losses on investments   (408)       (620)       (1,028)
 As at 31 March 2022 (audited)                 1,632       117,926     119,558
 Investments made during the period            -           6,403       6,403
 Disposal                                      -           (11)        (11)
 Unrealised fair value gains on investments*   102         7,476       7,578
 Unrealised fair value losses on investments*  -           (1,983)     (1,983)
 As at 30 September 2022 (unaudited)           1,734       129,811     131,545

* Excluding the demerger of Netacea Limited from Intechnica Holdings Limited
in the period

 

The measurement basis for determining the fair value of investments held is as
follows:

                                 Unaudited      Unaudited      Audited

                                 As at          As at          As at

                                 30 September   30 September   31 March

                                 2022           2021           2022

                                 £'000          £'000          £'000
 Quoted investment               1,734          2,040          1,632
 Price of last investment round  69,284         43,554         62,233
 Enterprise value                53,106         47,212         37,772
 Impaired value (1)              7,121          15,192         12,296
 Cost                            300            2,300          5,625
                                 131,545        110,298        119,558

(1) Valued using methodologies consistent with the Group's accounting policy

13. Cash, cash equivalents and short-term liquidity investments

                                   Unaudited      Unaudited      Audited

                                   As at          As at          As at

                                   30 September   30 September   31 March

                                   2022           2021           2022

                                   £'000          £'000          £'000
 Cash and cash equivalents         50,864         51,880         56,049
 Short-term liquidity investments  5,248          234            5,235

14. Deferred consideration

                                   Unaudited      Unaudited      Audited

                                   As at          As at          As at

                                   30 September   30 September   31 March

                                   2022           2021           2022

                                   £'000          £'000          £'000
 Payable within one year           2,869          1,578          2,869
 Payable within two to five years  -              2,869          -
                                   2,869          4,447          2,869

Details of the deferred consideration which arose on the acquisition of the
VCT fund management business in December 2019 are set out in the
Group's consolidated financial statements for the year ended 31 March 2022.

15. Deferred taxation

                         Unaudited      Unaudited      Audited

                         As at          As at          As at

                         30 September   30 September   31 March

                         2022           2021           2022

                         £'000          £'000          £'000
 Deferred tax liability  3,676          3,180          3,928

Under IAS 12 Income Taxes, provision is made for the deferred tax liability
associated with the recognition of the intangible asset arising on the
acquisition of the VCT fund management business. As at 30 September 2022 and
31 March 2022, the deferred tax liability has been calculated using the
substantively enacted tax rate of 25% (H1 2022: 19%).

16. Other distributable reserve

                                    Unaudited          Unaudited          Audited

                                    Six months ended   Six months ended   Year

                                    30 September       30 September       ended

                                    2022               2021               31 March

                                    £'000              £'000              2022

                                                                          £'000
 As at the beginning of the period  66,919             69,560             69,560
 Dividends (note 11)                (2,200)            (1,320)            (2,641)
 As at the end of the period        64,719             68,240             66,919

17. Fair value measurements

The fair values of the Group's financial assets and liabilities are considered
a reasonable approximation to the carrying values shown in the consolidated
statement of financial position. Subsequent to their initial recognition at
fair value, measurements of movements in fair values of financial instruments
are grouped into Levels 1 to 3, based on the degree to which the fair value is
observable.

The following table gives information about how the fair values of these
financial assets and financial liabilities are determined and presents the
Group's assets that are measured at fair value. There have been no movements
in financial assets or financial liabilities between levels during the current
or prior periods. The table in note 12 sets out the movement in the Level 1
and 3 financial assets during the period.

                                                                            Unaudited      Unaudited      Audited

                                                                            As at          As at          As at

                                                                            30 September   30 September   31 March

                                                                            2022           2021           2022

                                                                            £'000          £'000          £'000
 Assets:
 Financial assets at fair value through profit or loss - direct investment
 portfolio
 Level 1                                                                    1,734          2,040          1,632
 Level 2                                                                    -              -              -
 Level 3                                                                    129,811        108,258        117,926
                                                                            131,545        110,298        119,558

 

                                                                                   Unaudited         Unaudited      Audited

                                                                                   As at             As at          As at

                                                                                   30 September      30 September   31 March

                                                                                   2022              2021           2022

                                                                                   £'000             £'000          £'000
 Liabilities:
 Financial liabilities at fair value through profit or loss - deferred
 consideration
 Level 1                                                                           -                 -              -
 Level 2                                                                           -                 -              -
 Level 3                                                                           2,869             4,447          2,869
                                                                                   2,869             4,447          2,869

The Directors consider that the carrying amounts of financial assets and
financial liabilities recorded at amortised cost in the consolidated financial
statements approximate to their fair values.

Financial instruments in Level 1

The Group had one direct investment quoted on AIM, MyHealthChecked PLC, which
is fair valued using the closing bid price as at 30 September 2022, 30
September 2021 and 31 March 2022 respectively.

Financial instruments in Level 3

If one or more of the significant inputs required to fair value an instrument
is not based on observable market data, the instrument is included in Level 3.
Apart from the one investment classified in Level 1, all other investments
held in the Group's direct investment portfolio have been classified in Level
3 of the fair value hierarchy and the individual valuations for each of the
companies has been arrived at using appropriate valuation techniques.

The Group has adopted the International Private Equity and Venture Capital
Valuation Guidelines for determining its valuation techniques, which specify
that the price of a recent investment represents one of a number of inputs
used to arrive at fair value, and uses a single classification for all Level 3
investments.

Note 2 of the Group's consolidated financial statements for the year ended 31
March 2022 provides further information on the Group's valuation methodology,
including a detailed explanation of the valuation techniques used for Level 3
financial instruments.

18. Post balance sheet event

On 5 December 2022, the Group completed the acquisition of the entire share
capital of Frontier Development Capital Limited ("FDC") for a total
consideration of up to £9.5million, plus net cash. The acquisition is for an
initial consideration of £5.5million satisfied in cash, plus an amount equal
to FDC's net cash position (subject to certain adjustments) as at 30 November
2022. In addition, deferred consideration of up to £4.0million in cash will
be payable, contingent upon the achievement of future revenue and net new
institutional third-party fundraising targets, for the two years to 30
November 2024.

 

 

INDEPENDENT REVIEW REPORT TO MERCIA ASSET MANAGEMENT PLC

Introduction

We have been engaged by the Company to review the condensed set of financial
statements in the half-yearly financial report for the six months ended 30
September 2022 which comprises the condensed consolidated statement of
comprehensive income, condensed consolidated statement of financial position,
condensed consolidated statement of cash flows, condensed consolidated
statement of changes in equity and notes to the interim financial statements.

We have read the other information contained in the half-yearly financial
report and considered whether it contains any apparent misstatements or
material inconsistencies with the information in the condensed set of
financial statements.

Directors' responsibilities

The interim report, including the financial information contained therein, is
the responsibility of and has been approved by the directors. The directors
are responsible for preparing the interim report in accordance with the rules
of the London Stock Exchange for companies trading securities on AIM which
require that the half-yearly report be presented and prepared in a form
consistent with that which will be adopted in the Company's annual accounts
having regard to the accounting standards applicable to such annual accounts.

Our responsibility

Our responsibility is to express to the Company a conclusion on the condensed
set of financial statements in the half-yearly financial report based on our
review.

Scope of review

We conducted our review in accordance with International Standard on Review
Engagements (UK and Ireland) 2410, ''Review of Interim Financial Information
Performed by the Independent Auditor of the Entity'', issued by the Financial
Reporting Council for use in the United Kingdom. A review of interim financial
information consists of making enquiries, primarily of persons responsible for
financial and accounting matters, and applying analytical and other review
procedures. A review is substantially less in scope than an audit conducted in
accordance with International Standards on Auditing (UK) and consequently does
not enable us to obtain assurance that we would become aware of all
significant matters that might be identified in an audit. Accordingly, we do
not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to
believe that the condensed set of financial statements in the half-yearly
financial report for the six months ended 30 September 2022 is not prepared,
in all material respects, in accordance with the rules of the London Stock
Exchange for companies trading securities on AIM.

Use of our report

Our report has been prepared in accordance with the terms of our engagement to
assist the Company in meeting the requirements of the rules of the London
Stock Exchange for companies trading securities on AIM and for no other
purpose. No person is entitled to rely on this report unless such a person is
a person entitled to rely upon this report by virtue of and for the purpose of
our terms of engagement or has been expressly authorised to do so by our prior
written consent. Save as above, we do not accept responsibility for this
report to any other person or for any other purpose and we hereby expressly
disclaim any and all such liability.

 

BDO LLP

Chartered Accountants

London, UK

5 December 2022

BDO LLP is a limited liability partnership registered in England and Wales
(with registered number OC305127).

 

 

Directors, secretary and advisers

 

Directors

Ian Roland Metcalfe
 (Non-executive Chair)

Dr Mark Andrew
Payton                               (Chief
Executive Officer)

Martin James Glanfield                                (Chief
Financial Officer)

Julian George Viggars
 (Chief Investment Officer)

Diane
Seymour-Williams
(Senior Independent Director)

Raymond Kenneth Chamberlain                  (Non-executive Director)

Dr Jonathan David
Pell
(Non-executive Director)

Caroline Bayantai Plumb OBE                       (Non-executive
Director)

 

 Company secretary      Company registration number
 Sarah-Louise Williams  09223445

 Company website        Company registrar
 www.mercia.co.uk       SLC Registrars
                        Highdown House
 Registered office      Yeoman Way
 Forward House          Worthing
 17 High Street         West Sussex BN99 3HH
 Henley-in-Arden
 Warwickshire B95 5AA   Solicitors
                        Gowling WLG (UK) LLP
 Independent auditor    4 More London Riverside
 BDO LLP                London SE1 2AU
 55 Baker Street
 Marylebone             Nominated adviser and joint broker
 London W1U 7EU         Canaccord Genuity Ltd
                        88 Wood Street
 Principal bankers      London EC2V 7QR
 Barclays Bank PLC
 One Snowhill           Joint broker
 Snow Hill Queensway    Singer Capital Markets Advisory LLP
 Birmingham B4 6GN      1 Bartholomew Lane
                        London EC2N 2AX
 Lloyds Bank plc
 125 Colmore Row        Investor relations adviser
 Birmingham B3 3SD      FTI Consulting Ltd
                        200 Aldersgate
                        London EC2A 4HD

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR LELLBLLLBFBK

Recent news on Mercia Asset Management

See all news